Navigation Links
Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013
Date:6/21/2013

We have adjourned the meeting to allow stockholders additional time to vote or change their preferences in favor of the proposals. While both remaining proposals have been favored by greater than 60% of shares voted, they each also require a majority of all outstanding shares, many of which have not yet been voted."

Proposal five gives Cardium's Board of Directors the authority to effect a reverse split of the Company's outstanding common stock.  Proposal six provides for an amendment to the Company's Amended and Restate Certificate of Corporation – which amendment would ONLY be entered in the event that Proposal 5 is not approved – and which would allow for the increase in the number of authorized shares of common stock of the Company. Each of the proposals is described in detail in the Company's definitive proxy statement for the Annual Meeting as filed with the Securities and Exchange Commission and available from the Company and on its website.

During the period of the adjournment, Cardium will continue to solicit proxies from its stockholders with respect to the remaining two proposals.  Stockholders who have already voted need not take any action on the proposal, although they may change their vote for the Proposals by executing a new proxy, revoking a previously given proxy as set forth in Cardium's proxy statement, or by calling 888-219-8320.   

Cardium's proxy statement and any other materials filed by the Company with the SEC can be obtained free of charge at the SEC's website at www.sec.gov or from the Company's website at www.cardiumthx.com.  Only stockholders who held the Company's common stock as of the record date of April 26, 2013 are eligible to vote.

About Cardium        

Cardium is an asset-based health sciences and regenerative medicine company focused o
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan
2. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
3. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
4. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
5. Cardium to Present at Upcoming Investor Conferences
6. China Green Agriculture Inc. Announces Ministry of Agriculture Engaged Gufeng as Corporate Participant in the Ministrys Fertilizer Promotion Program
7. Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System
8. Techne Corporation Announces Acquisition Agreement
9. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
10. Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions
11. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 Earlier this year ... L. Sherley, director of the Adult Stem Cell Technology ... often overlooked and under appreciated unique property of adult ... Distributed Stem Cells: Misunderstood in the Past, Important for ... congress participants. He gave the address at the ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 23, 2014 ... on methyl mercaptan such as its definition, ... also presents product specification, manufacturing process, and ... regions, technology and applications. The analysis also ... survey, marketing channels, industry development trend and ...
(Date:12/24/2014)... BEIJING , Dec. 23, 2014 ... or the "Company"), a leading fully integrated plasma-based ... today announced that its majority-owned subsidiary, Shandong Taibang ... Practices ("GMP") certification from the China Food and ... factor production facility. As previously disclosed in the ...
(Date:12/24/2014)...  Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... Trial Application (CTA) with the United Kingdom,s ... regulatory approval to initiate clinical trials for the continued ... Contingent on the Company receiving CTA regulatory approval, the ... assess the safety, tolerability and dose escalation of Anatabine ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Nfocus device development team.PALO ALTO, Calif., April 30 ... today the appointment of accomplished regulatory executive Robert O,Holla ... President of Regulatory Affairs. "Bob O,Holla brings an unmatched ... , having served 18 of his last 30 years ...
... April 30 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ... of drugs for the treatment of human viral diseases, today ... 31, 2009. At March 31, 2009, Idenix,s cash, cash equivalents ... , , ...
... Resonant Medical, an innovator in 3D ultrasound image-guided ... Stephen Whisenhunt to the position of Vice President ... the Company,s growing global sales team and manage ... years of radiation oncology industry experience to the ...
Cached Biology Technology:Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2Idenix Pharmaceuticals Reports First Quarter Financial Results 2Idenix Pharmaceuticals Reports First Quarter Financial Results 3Idenix Pharmaceuticals Reports First Quarter Financial Results 4Idenix Pharmaceuticals Reports First Quarter Financial Results 5Idenix Pharmaceuticals Reports First Quarter Financial Results 6Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing 2
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
(Date:12/10/2014)... -- You,ve been here before: you desperately need to sign ... site key or the answer to your secret question. What,s ... Today, Hoyos Labs , a digital infrastructure ... put an end to the frustration that comes with usernames, ... leverages a user,s smartphone to acquire his or her biometrics ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... it." The saying could apply especially to the brain ... studies have shown that keeping the mind active, exercising ... dementia in Alzheimer,s disease. Now, a new ... Center for Neurologic Diseases in the BWH Department of ...
... 5.8 million Americans suffer from heart failure, a currently ... Medicine,s (TUSM) Center for Translational Medicine have discovered a ... the development of new drugs to treat and possibly ... failure are not very effective," explained lead investigator Walter ...
... A team of European scientists from the University Medical Center ... Cellular Stress Responses in Aging-Associated Diseases (CECAD) at the ... closer to understanding the root cause of age-related dementia. In ... age-related dementia is likely the result of a declining ability ...
Cached Biology News:Use it or lose it 2Temple researchers discover key to heart failure, new therapies on horizon 2Temple researchers discover key to heart failure, new therapies on horizon 3Age-related dementia may begin with neurons' inability to dispose of unwanted proteins 2
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z71,381-3) or ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... Anti-YAP Polyclonal Antibody ... purified rabbit polyclonal antibody. Detects 70 ... in Western blotting and immunohistochemistry. ... proliferation Storage: ...
... Stain for Mass Spectrometry Applications ,In ... (MS) has emerged as a powerful protein ... 2-D gels is now an important intermediate ... leads ultimately to identification of specific proteins ...
Biology Products: